Suma Krishnan
President, Research and Development
Other
COO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Krystal Biotech, Inc. (KRYS) | President, R&D | $677,500 | $6,948,401 |
| 2024 | Krystal Biotech, Inc. (KRYS) | President, R&D | $639,167 | $8,243,817 |
| 2023 | Krystal Biotech, Inc. (KRYS) | President, R&D | $575,000 | $3,835,481 |
| 2022 | Krystal Biotech, Inc. (KRYS) | President, R&D | $514,833 | $2,979,559 |
| 2021 | Krystal Biotech, Inc. (KRYS) | President, R&D | $453,359 | $5,123,121 |
| 2020 | Krystal Biotech, Inc. (KRYS) | President, R&D | $392,215 | $602,976 |
| 2019 | Krystal Biotech, Inc. (KRYS) | Chief Operating Officer | $305,642 | $305,642 |
| 2018 | Krystal Biotech, Inc. (KRYS) | Chief Operating Officer | $200,000 | $495,444 |
Earnings-call appearances
-
First Quarter 2026 Earnings Call2026-05-04
Krystal Biotech, Inc. (KRYS)
-
Krystal Biotech, Inc. Q4 FY2025 Earnings Call2026-02-17
Krystal Biotech, Inc. (KRYS)
-
Krystal Biotech, Inc. Q3 FY2025 Earnings Call2025-11-03
Krystal Biotech, Inc. (KRYS)
-
Krystal Biotech, Inc. Q1 FY2025 Earnings Call2025-05-06
Krystal Biotech, Inc. (KRYS)
-
Krystal Biotech, Inc. Q4 FY2024 Earnings Call2024-12-31
Krystal Biotech, Inc. (KRYS)
-
Krystal Biotech, Inc. Q3 FY2024 Earnings Call2024-11-04
Krystal Biotech, Inc. (KRYS)
-
Krystal Biotech, Inc. Q1 FY2024 Earnings Call2024-05-06
Krystal Biotech, Inc. (KRYS)
-
Krystal Biotech, Inc. Q4 FY2023 Earnings Call2024-02-26
Krystal Biotech, Inc. (KRYS)
-
Krystal Biotech, Inc. Q3 FY2023 Earnings Call2023-11-06
Krystal Biotech, Inc. (KRYS)